Losartan hair loss is best approached with timeline logic, because most medication-linked shedding behaves like telogen effluvium (TE): the trigger happens first, and increased shedding becomes noticeable later. For losartan, the most useful evidence is not a vague class claim, but a combination of molecule-level label support, controlled-trial context, and pattern + timing. Official losartan labeling includes alopecia among reported skin reactions, but the same labeling also shows that overall adverse-event rates in hypertension trials were similar to placebo, and the common events reported more often than placebo were things like dizziness, nasal congestion, upper respiratory infection, sinusitis, and back pain—not alopecia. In practical terms, if losartan-related shedding is real, it usually makes more sense to interpret it through TE timing and a diffuse pattern than through a “common side effect” assumption.
Medical note: This article is for general education and does not provide personal medical advice. Do not stop or change losartan without clinician guidance. If you are not sure whether you are seeing shedding or breakage, start here: Shedding vs Breakage. If the diagnosis is unclear, start here: How Hair Loss Is Diagnosed. If you have scalp pain/burning, pustules/crusting, heavy scale, open sores, facial swelling, or rapid worsening, start here: When to See a Doctor.
Quick navigation
- Key takeaways
- What the product information says / what it doesn’t
- Timeline: onset, peak, recovery
- Pattern clues: TE vs AGA vs AA vs breakage
- When labs matter
- What to do
- When to see a doctor
- FAQ
- References
Key takeaways
- Label signal exists: official losartan labeling lists alopecia among reported skin reactions.
- But it is not a strong common-event signal: in placebo-controlled hypertension trials, the overall adverse-event profile was similar to placebo, and the events reported more often than placebo included dizziness, nasal congestion, upper respiratory infection, sinusitis, and back pain, not alopecia.
- TE timing is delayed: increased hair fall is often noticed about 2–4 months after a trigger and may occur around 3 months after a trigger.
- Pattern matters: medication-linked TE is usually diffuse and non-scarring, not a single smooth bald patch.
- Do not self-stop: if timing fits, the next step is clinician-guided risk/benefit review, not abrupt discontinuation.
- Related on this site: ARB Hair Loss: Risk & Timeline • Medication-Related Shedding • Telogen Effluvium • ACE Inhibitor Hair Loss: Risk & Timeline • Beta-Blocker Hair Loss: Risk, Timeline & Fixes.
What the product information says / what it doesn’t
What supports plausibility: losartan has molecule-level label support. In DailyMed, alopecia appears among reported skin reactions.
What the main trial data say: losartan was generally well tolerated in controlled hypertension studies, the overall incidence of reported adverse experiences was similar to placebo, and discontinuation due to clinical adverse experiences was actually 2.3% with losartan versus 3.7% with placebo in those trials.
What showed up more often than placebo: the adverse events reported in 1% or more of losartan-treated patients and more commonly than placebo included dizziness, nasal congestion, upper respiratory infection, sinusitis, back pain, muscle cramp, and leg pain. That is important because it shows that alopecia is a reported signal, but not one of the dominant common trial-table adverse effects.
Practical interpretation: if someone develops diffuse shedding while taking losartan, the useful next step is not to stop at the word alopecia in the label. The real question is whether the timeline fits TE, whether the pattern is diffuse, and whether there were other triggers in the same 2–4 month window.
Timeline: onset, peak, recovery
For most practical suspected medication-shedding cases, the most useful model is telogen effluvium.
- Onset: the key clue is delay. Hair fall is often noticed about 2–4 months after a trigger and can occur around 3 months after a trigger.
- Peak: once shedding starts, it may feel worst for several weeks.
- Recovery: once the trigger is addressed or stabilizes, shedding usually slows first; visible density recovery takes longer.
- Duration clue: acute TE shedding often lasts about 3–6 months, but cosmetic regrowth usually takes longer.
This delay is why people often miss the connection. Someone may start losartan, feel fine for weeks, and only later notice more hair in the shower, on the pillow, or on the brush. That pattern is much more consistent with hair-cycle timing than with a dramatic same-week reaction.
Pattern clues: TE vs AGA vs AA vs breakage
Most consistent with TE
Medication-linked TE usually looks like diffuse shedding with a generally normal-looking scalp. You notice more hair fall all over, not one sharply defined bald patch.
TE + androgenetic alopecia overlap
If shedding improves but the part line keeps widening or the crown continues to thin, think about overlap with telogen effluvium vs androgenetic alopecia.
Alopecia areata is a different pattern
If you have patchy, smooth, well-defined bald areas, that is less typical for medication-triggered TE and should raise the question of alopecia areata.
Breakage is not the same as shedding
If you mostly see short snapped hairs, rough texture, or frayed ends, that points more toward hair breakage than true root-level shedding.
If the scalp is inflamed, think broader than TE
TE is usually a non-scarring diffuse shedding pattern without obvious inflammation. If the scalp is very itchy, red, painful, crusted, or visibly irritated, a simple TE explanation becomes less complete and you should review for another scalp disorder, another drug reaction, or a different diagnosis.
When labs matter
Not every patient with a plausible medication timeline needs a broad lab panel. But labs matter more when shedding is heavy, persistent, recurrent, or the history suggests overlap causes such as iron deficiency, thyroid disease, major weight change, illness, dietary restriction, or another systemic stressor in the same window.
For the site workup roadmap, use: Blood Tests & Workup.
What to do (practical plan)
- Build the timeline: write down the losartan start date, any dose changes, and the month shedding became noticeable.
- Confirm the pattern: diffuse shedding vs breakage vs overlap pattern hair loss vs patchy loss.
- Review stacked triggers: illness, fever, surgery, postpartum timing, dieting, weight loss, thyroid issues, low iron, or major stress in the same 2–4 month window.
- Review the exact formulation: losartan alone vs combination treatment, because combination products can complicate attribution.
- Talk to the prescriber: if timing fits, discuss cardiovascular risk/benefit and whether any alternative is reasonable. Do not self-stop.
- Avoid supplement roulette: add supplements only when history, labs, or clinician guidance supports a deficiency.
- Track monthly: use photos every 4 weeks in the same lighting and angle so you can judge trend, not day-to-day anxiety.
When to see a doctor
- Scalp pain, burning, pustules, open sores, or heavy scale/crusting
- Patchy smooth bald spots rather than diffuse shedding
- Obvious eyebrow or eyelash involvement
- Facial swelling or other possible medication-reaction symptoms
- Shedding that persists beyond about 6 months or returns in repeated waves
- Unclear diagnosis or rapid worsening
Start here: When to See a Doctor.
FAQ
Is losartan hair loss permanent?
When the pattern behaves like telogen effluvium, it is usually non-scarring and reversible once the trigger stabilizes, but regrowth takes time.
Does the losartan label prove it caused my shedding?
No. The label supports plausibility, but it does not prove individual causation. Causation still depends on timing, pattern, and whether there were other triggers in the same window.
Why does shedding start months later?
Because TE is delayed. The trigger shifts more hairs into the resting phase first, and the increased shedding becomes noticeable later.
Should I stop losartan if I suspect shedding?
No. Do not stop it on your own. The safer next step is to review the timeline and treatment context with the prescriber first.
References (trusted sources)
- DailyMed: Losartan potassium — alopecia listed among skin reactions; controlled-trial adverse events and tolerability context
- DermNet: Telogen effluvium — increased hair fall is often noticed 2 to 4 months after the triggering event
- British Association of Dermatologists: Telogen effluvium — can occur around 3 months after a trigger; shedding phase usually lasts 3 to 6 months
- DermNet: Alopecia from drugs — medication-related alopecia commonly behaves like telogen effluvium
- NCBI Bookshelf (StatPearls): Telogen Effluvium
Last updated: March 12, 2026.
